SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-19-000474
Filing Date
2019-01-29
Accepted
2019-01-29 11:48:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 BIOPHARMX CORPORATION p19-0277sc13ga.htm SC 13G/A 91150
  Complete submission text file 0000902664-19-000474.txt   92708
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

IRS No.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Subject) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: SC 13G/A | Act: 34 | File No.: 005-87755 | Film No.: 19547719
SIC: 2834 Pharmaceutical Preparations